Replimune Group, Inc. (REPL) financial statements (2022 and earlier)

Company profile

Business Address 500 UNICORN PARK
WOBURN, MA 01801
State of Incorp. DE
Fiscal Year End March 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments420,172476,302168,555134,811
Cash and cash equivalents132,275182,51859,50025,704
Short-term investments287,897293,784109,055109,107
Deferred costs   2,157
Other undisclosed current assets7,6237,4455,6964,013
Total current assets:427,795483,747174,251140,981
Noncurrent Assets
Finance lease, right-of-use asset42,70144,522 
Operating lease, right-of-use asset5,7385,751 
Property, plant and equipment7,4127,4426,86012,159
Restricted cash and investments1,6361,6361,6361,186
Other undisclosed noncurrent assets  51,350 
Total noncurrent assets:57,48759,35159,84613,345
TOTAL ASSETS:485,282543,098234,097154,326
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,8317,2286,5819,355
Accounts payable3,9222,3553,4347,084
Accrued liabilities1,4009211,082761
Employee-related liabilities4,5093,9522,0651,510
Debt2,5432,487  
Other undisclosed current liabilities5,9174,8325,293530
Total current liabilities:18,29114,54711,8749,885
Noncurrent Liabilities
Long-term debt and lease obligation29,48229,823  
Finance lease, liability24,50124,745 
Operating lease, liability4,9815,078 
Liabilities, other than long-term debt   24
Deferred rent credit   24
Other undisclosed noncurrent liabilities(4,981)(5,078)38,5056,561
Total noncurrent liabilities:29,48229,82338,5056,585
Total liabilities:47,77344,37050,37916,470
Stockholders' equity
Stockholders' equity attributable to parent437,509498,728183,718137,856
Common stock47473732
Additional paid in capital717,151692,243296,961198,645
Accumulated other comprehensive loss(181)(394)(982)(1,055)
Accumulated deficit(279,508)(193,168)(112,298)(59,766)
Total stockholders' equity:437,509498,728183,718137,856
TOTAL LIABILITIES AND EQUITY:485,282543,098234,097154,326

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
Operating expenses(86,326)(79,955)(56,198)(30,946)
Operating loss:(86,326)(79,955)(56,198)(30,946)
Nonoperating income (expense)(14)(915)3,573112
Investment income, nonoperating2599162,4242,585
Other nonoperating income (expense)(849)(665)(16)451
Interest and debt expense(1,670)(913)(734) 
Other undisclosed income from continuing operations before equity method investments, income taxes 913734 
Loss before gain (loss) on sale of properties:(88,010)(80,870)(52,625)(30,834)
Other undisclosed net income558  61,668
Net income (loss):(87,452)(80,870)(52,625)30,834
Other undisclosed net income (loss) attributable to parent1,112  (61,668)
Net loss available to common stockholders, diluted:(86,340)(80,870)(52,625)(30,834)

Comprehensive Income ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
Net income (loss):(87,452)(80,870)(52,625)30,834
Comprehensive income (loss):(87,452)(80,870)(52,625)30,834
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1,32558873(62,485)
Comprehensive loss, net of tax, attributable to parent:(86,127)(80,282)(52,552)(31,651)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: